Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2013-09-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
arrange laser acupuncture intervention for 12 weeks, then cross over to sham laser acupuncture intervention for 12 weeks
Handylaser Trion laser acupuncture
intervention interval is 3 times per week for 12 weeks
Group 2
arrange sham laser acupuncture for 12 weeks, then cross over to laser acupuncture for 12 weeks
Handylaser Trion laser acupuncture
intervention interval is 3 times per week for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Handylaser Trion laser acupuncture
intervention interval is 3 times per week for 12 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Epilepsy history
* Pregnancy
* Immuno-inhibiting agents user
* Malignancy
* Skin contacted disease
* Weight controlled agents user during trial period
* Eating disorder
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaohsiung Medical University Chung-Ho Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cheng-Che Lin
Doctor of Chinese Medicine Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cheng-Che Lin, MD
Role: STUDY_CHAIR
Doctor of Chinese Medicine Department, Kaohsiung Medical University Hospital
Hung-Yi Chuang, ScD, MD
Role: STUDY_DIRECTOR
Department of Public Health, College of Health Sciences, Kaohsiung Medical University
Chen-Cheng Yang, MD
Role: PRINCIPAL_INVESTIGATOR
Family Medicine Department, Kaohsiung Medical University Hospital and Kaohsiung Municipal Ta-Tung Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese Medicine Department Clinic, Kaohsiung Medical University
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Cheng-Che Lin
Role: primary
Chen-Cheng Yang
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Wozniak P, Stachowiak G, Pieta-Dolinska A, Oszukowski P. Laser acupuncture and low-calorie diet during visceral obesity therapy after menopause. Acta Obstet Gynecol Scand. 2003 Jan;82(1):69-73. doi: 10.1034/j.1600-0412.2003.820113.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMUH-LAAC-OB-001
Identifier Type: -
Identifier Source: org_study_id